IP Library Granted Patent US 10,822,624
Granted Patent B2
US 10,822,624 · App. 16/405,089 · Granted Nov 3, 2020

Compositions and methods for recombinant biosynthesis of propane

Inventors: Nigel Scrutton (Cheshire, GB); Patrik Jones (Bromley, GB); Navya Menon (Manchester, GB)
Assignee: C3 BIO-TECHNOLOGIES LIMITED
C12P5/02C12N9/001C12N9/0006C12N9/0008C12N9/1029C12N9/1288C12N9/16C12N9/88C12N15/52C12P7/16C12Y101/01001C12Y101/01021C12Y101/01157C12Y102/99006C12Y103/01038C12Y203/01009C12Y203/01194C12Y207/08007C12Y301/0202C12Y401/99005C12Y402/01055
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,822,624
App. No.
16/405,089
Granted
Nov 3, 2020
Kind
B2
Abstract

Provided are genetically engineered microorganism that catalyze the synthesis of propane and/or butanol from a suitable substrate such as glucose. Also provided are methods of engineering said genetically engineered microorganism and methods of producing propane and/or butanol using the genetically engineered microorganism.

Claims (44)

1. A genetically engineered bacterium, which expresses both an enzyme for butyraldehyde synthesis and a heterologous polypeptide having aldehyde deformylating oxygenase activity and produces propane from butyraldehyde as a precursor independent of fatty acid synthesis pathways.

2. The genetically engineered bacterium of claim 1 , which further produces butanol.

3. The genetically engineered bacterium of claim 1 , wherein propane is produced independent of aldehyde-alcohol dehydrogenase (AdhE2).

4. The genetically engineered bacterium of claim 1 , comprising a deletion of aldehyde reductase (Δahr) enzyme, alcohol dehydrogenase (ΔyqhD) enzyme or a combination thereof.

5. The genetically engineered bacterium of claim 4 , wherein the bacterium has been transformed with a first plasmid vector comprising a first nucleotide sequence encoding a polypeptide having acetyl-CoA acetyltransferase (AtoB) activity, a second nucleotide sequence encoding a polypeptide having 3-hydroxybutyrl-CoA dehydrogenase (Hbd) activity, a third nucleotide sequence encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase (Crt) activity and a fourth nucleotide sequence encoding a polypeptide having trans-2-enoyl-CoA reductase (Ter) activity.

6. The genetically engineered bacterium of claim 5 , wherein the bacterium has been co-transformed with a second plasmid vector selected from the group consisting of:

a second plasmid vector comprising a first nucleotide sequence encoding a polypeptide having acyl-CoA thioester hydrolase (YciA) activity, a second nucleotide sequence encoding a polypeptide having the activity of a maturation factor for phosphopantetheinyl transferase (Sfp) and a third nucleotide sequence encoding a polypeptide having carboxylic acid reductase (CAR) activity; and

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde-alcohol dehydrogenase (AdhE2) activity.

7. The genetically engineered bacterium of claim 1 , wherein the bacterium has been transformed with a first plasmid vector comprising a first nucleotide sequence encoding a polypeptide having acetyl-CoA acetyltransferase (AtoB) activity, a second nucleotide sequence encoding a polypeptide having 3-hydroxybutyrl-CoA dehydrogenase (Hbd) activity, a third nucleotide sequence encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase (Crt) activity and a fourth nucleotide sequence encoding a polypeptide having trans-2-enoyl-CoA reductase (Ter) activity.

8. The genetically engineered bacterium of claim 7 , wherein the bacterium has been co-transformed with a second plasmid vector selected from the group consisting of:

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde-alcohol dehydrogenase (AdhE2) activity; and

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having acyl-CoA thioester hydrolase (YciA) activity, a second nucleotide sequence encoding a polypeptide having the activity of a maturation factor for phosphopantetheinyl transferase (Sfp) and a third nucleotide sequence encoding a polypeptide having carboxylic acid reductase (CAR) activity.

9. The genetically engineered bacterium of claim 1 , wherein the bacterium has been transformed with a first plasmid vector comprising a first nucleotide sequence encoding a polypeptide having acetoacetyl-CoA synthase (NphT7) activity, a second nucleotide sequence encoding a polypeptide having 3-hydroxybutyrl-CoA dehydrogenase (Hbd) activity, a third nucleotide sequence encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase (Crt) activity and a fourth nucleotide sequence encoding a polypeptide having trans-2-enoyl-CoA reductase (Ter) activity.

10. The genetically engineered bacterium of claim 9 , wherein the bacterium has been transformed with a second plasmid vector selected from the group consisting of:

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde-alcohol dehydrogenase (AdhE2) activity; and

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having acyl-CoA thioester hydrolase (YciA) activity, a second nucleotide sequence encoding a polypeptide having the activity of a maturation factor for phosphopantetheinyl transferase (Sfp) and a third nucleotide sequence encoding a polypeptide having carboxylic acid reductase (CAR) activity.

11. The genetically engineered bacterium of claim 9 , wherein the bacterium has been co-transformed with a second plasmid vector selected from the group consisting of:

a second plasmid vector comprising a first nucleotide sequence encoding a polypeptide having acyl-CoA thioester hydrolase (YciA) activity, a second nucleotide sequence encoding a polypeptide having activity of a maturation factor for phosphopantetheinyl transferase (Sfp) and a third nucleotide sequence encoding a polypeptide having carboxylic acid reductase (Car) activity; and

a second plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde-alcohol dehydrogenase (AdhE2) activity.

12. The genetically engineered bacterium of claim 11 wherein the bacterium has been co-transformed with a third plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde deformylating oxygenase (ADO) activity.

13. The genetically engineered bacterium of claim 11 , wherein the bacterium has been co-transformed with a third plasmid vector comprising a nucleotide sequence encoding a polypeptide having aldehyde deformylating oxygenase activity wherein alanine at position 134 is substituted with phenylalanine (ADOA 134 F).

14. The genetically engineered bacterium of claim 12 , wherein the bacterium further comprises a polynucleotide encoding one or more ferredoxins so as to increase supply of electrons.

15. The genetically engineered bacterium of claim 14 , the ferredoxin is PetF (ssl0020).

16. The genetically engineered bacterium of claim 1 which further expresses:

(i) a heterologous polypeptide having acetyl-CoA acetyltransferase activity;

(ii) a heterologous polypeptide having 3-hydroxybutyrl-CoA dehydrogenase activity;

(iii) a heterologous polypeptide having 3-hydroxybutyryl-CoA dehydratase activity;

(iv) a heterologous polypeptide having trans-2-enoyl-CoA reductase activity; and

(v) a heterologous polypeptide having aldehyde-alcohol dehydrogenase activity.

17. The genetically engineered bacterium of claim 1 which further expresses:

(i) a heterologous polypeptide having acetyl-CoA acetyltransferase activity;

(ii) a heterologous polypeptide having 3-hydroxybutyrl-CoA dehydrogenase activity;

(iii) a heterologous polypeptide having 3-hydroxybutyryl-CoA dehydratase activity;

(iv) a heterologous polypeptide having trans-2-enoyl-CoA reductase activity;

(v) a heterologous polypeptide having acyl-CoA thioester hydrolase activity;

(vi) a heterologous polypeptide having the activity of a maturation factor for phosphopantetheinyl transferase; and

(vii) a heterologous polypeptide having carboxylic acid reductase activity.

18. The genetically engineered bacterium of claim 1 , wherein the enzyme for butyraldehyde synthesis is endogenously expressed.

19. A method for producing propane comprising:

providing the genetically engineered bacterium of claim 1 ; and

culturing the bacterium, so as to produce propane.

20. A method for producing butanol comprising:

providing the genetically engineered bacterium of claim 2 ; and

culturing the bacterium, so as to produce butanol.

Assignments (3)
CHANGE OF NAME Recorded Aug 11, 2021
From: C3 BIO-TECHNOLOGIES LIMITED
To: C3 BIOTECHNOLOGIES LIMITED
Reel/Frame 057145/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: THE UNIVERSITY OF MANCHESTER
To: C3 BIO-TECHNOLOGIES LIMITED
Reel/Frame 049712/0457 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: SCRUTTON, NIGEL; JONES, PATRIK; MENON, NAVYA
To: THE UNIVERSITY OF MANCHESTER
Reel/Frame 049101/0446 →
Continuity (3)
Continuation 15421861 · Feb 1, 2017
Provisional Application 62289517 · Feb 1, 2016
Related Publication 20190323040A1 · Oct 24, 2019